checkAd

     335  0 Kommentare Valneva Reports FY 2020 Cash of Over €200 Million - Seite 2


    Valneva Investor and Media Contacts
    Laetitia Bachelot-Fontaine
    Global Head of Investor Relations &
    Corporate Communications
    M +33 (0)6 4516 7099
    investors@valneva.com        
     

    Teresa Pinzolits
    Corporate Communications Specialist
    T +43 (0)1 20620 1116
    communications@valneva.com

    Forward-Looking Statements

    This press release contains certain forward-looking statements relating to the business of Valneva. Even if the actual results or development of Valneva are consistent with the forward-looking statements contained in this press release, those results or developments of Valneva may not be indicative of their in the future. In some cases, you can identify forward-looking statements by words such as "could," "should," "may," "expects," "anticipates," "believes," "intends," "estimates," "aims," "targets," or similar words. These forward-looking statements are based largely on the current expectations of Valneva as of the date of this press release and are subject to a number of known and unknown risks and uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievement expressed or implied by these forward-looking statements. In particular, the expectations of Valneva could be affected by, among other things, uncertainties involved in the development and manufacture of vaccines, unexpected clinical trial results, unexpected regulatory actions or delays, competition in general, currency fluctuations, the impact of the global and European credit crisis, and the ability to obtain or maintain patent or other proprietary intellectual property protection. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements made during this presentation will in fact be realized. Valneva is providing the information in these materials as of this press release, and disclaim any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

    Seite 2 von 3



    Diskutieren Sie über die enthaltenen Werte



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Valneva Reports FY 2020 Cash of Over €200 Million - Seite 2 FY 2020 cash and cash equivalents of €204.4 million, exceeding guidance of between €180 million and €200 million1FY 2020 cash and cash equivalents include $130 million from the Lyme disease collaboration with Pfizer2 and €96.7 million from the UK …

    Schreibe Deinen Kommentar

    Disclaimer